• UroGen Pharma Ltd. (NASDAQ:URGN) Receives Average Recommendation of "Buy" from Analysts

    Source: Buzz FX / 16 Mar 2025 02:16:17   America/New_York


    UroGen Pharma Ltd. (NASDAQ:URGN) Receives Average Recommendation of "Buy" from Analysts Written by MarketBeat March 16, 2025 Share Link copied to clipboard. Remove Ads UroGen Pharma Ltd. ( NASDAQ:URGN - Get Free Report ) has received a cons
    Read more...
Share on,